FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1626677331> ?p ?o ?g. }

• W1626677331 endingPage "R1296" @default.
• W1626677331 startingPage "R1296" @default.
• W1626677331 abstract "The aim of the present study was to investigate the association between exposure to mineral oil and the risk of developing rheumatoid arthritis (RA), and in addition to perform a separate analysis on the major subphenotypes for the disease; namely, rheumatoid factor (RF)-positive RA, RF-negative RA, anticitrulline-positive RA and anticitrulline-negative RA, respectively. A population-based case–control study of incident cases of RA was performed among the population aged 18–70 years in a defined area of Sweden during May 1996–December 2003. A case was defined as an individual from the study base who for the first time received a diagnosis of RA according to the American College of Rheumatology criteria of 1987. Controls were randomly selected from the study base with consideration taken for age, gender and residential area. Cases (n = 1,419) and controls (n = 1,674) answered an extensive questionnaire regarding lifestyle factors and occupational exposures, including different types of mineral oils. Sera from cases and controls were investigated for RF and anticitrulline antibodies. Among men, exposure to any mineral oil was associated with a 30% increased relative risk of developing RA (relative risk = 1.3, 95% confidence interval = 1.0–1.7). When cases were subdivided into RF-positive RA and RF-negative RA, an increased risk was only observed for RF-positive RA (relative risk = 1.4, 95% confidence interval 1.0–2.0). When RA cases were subdivided according to the presence of anticitrulline antibodies, an increased risk associated with exposure to any mineral oil was observed only for anticitrulline-positive RA (relative risk = 1.6, 95% confidence interval = 1.1–2.2). Analysis of the interaction between oil exposure and the presence of HLA-DR shared epitope genes regarding the incidence of RA indicated that the increased risk associated with exposure to mineral oil was not related to the presence of shared epitope genotypes. In conclusion, our study shows that exposure to mineral oil is associated with an increased risk to develop RF-positive RA and anticitrulline-positive RA, respectively. The findings are of particular interest since the same mineral oils can induce polyarthritis in rats." @default.
• W1626677331 created "2016-06-24" @default.
• W1626677331 creator A5007250146 @default.
• W1626677331 creator A5018005178 @default.
• W1626677331 creator A5051930598 @default.
• W1626677331 creator A5054967707 @default.
• W1626677331 creator A5071141746 @default.
• W1626677331 creator A5075011519 @default.
• W1626677331 creator A5082575419 @default.
• W1626677331 date "2005-01-01" @default.
• W1626677331 modified "2023-10-10" @default.
• W1626677331 cites W1567434519 @default.
• W1626677331 cites W1963232440 @default.
• W1626677331 cites W1963603430 @default.
• W1626677331 cites W1969813387 @default.
• W1626677331 cites W2002870939 @default.
• W1626677331 cites W2006835355 @default.
• W1626677331 cites W2010188124 @default.
• W1626677331 cites W2015865604 @default.
• W1626677331 cites W2025408360 @default.
• W1626677331 cites W2039684625 @default.
• W1626677331 cites W2043825105 @default.
• W1626677331 cites W2064426268 @default.
• W1626677331 cites W2066629760 @default.
• W1626677331 cites W2069056316 @default.
• W1626677331 cites W2080476217 @default.
• W1626677331 cites W2088098893 @default.
• W1626677331 cites W2093120748 @default.
• W1626677331 cites W2115692677 @default.
• W1626677331 cites W2129389823 @default.
• W1626677331 cites W2146368947 @default.
• W1626677331 cites W2146863995 @default.
• W1626677331 cites W2152348310 @default.
• W1626677331 cites W2158850561 @default.
• W1626677331 cites W2163521262 @default.
• W1626677331 cites W2170918605 @default.
• W1626677331 cites W2171619703 @default.
• W1626677331 cites W2172150816 @default.
• W1626677331 cites W38621296 @default.
• W1626677331 cites W52089534 @default.
• W1626677331 doi "https://doi.org/10.1186/ar1824" @default.
• W1626677331 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1297574" @default.
• W1626677331 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16277683" @default.
• W1626677331 hasPublicationYear "2005" @default.
• W1626677331 type Work @default.
• W1626677331 sameAs 1626677331 @default.
• W1626677331 citedByCount "103" @default.
• W1626677331 countsByYear W16266773312012 @default.
• W1626677331 countsByYear W16266773312013 @default.
• W1626677331 countsByYear W16266773312014 @default.
• W1626677331 countsByYear W16266773312015 @default.
• W1626677331 countsByYear W16266773312016 @default.
• W1626677331 countsByYear W16266773312017 @default.
• W1626677331 countsByYear W16266773312018 @default.
• W1626677331 countsByYear W16266773312019 @default.
• W1626677331 countsByYear W16266773312020 @default.
• W1626677331 countsByYear W16266773312021 @default.
• W1626677331 countsByYear W16266773312022 @default.
• W1626677331 countsByYear W16266773312023 @default.
• W1626677331 crossrefType "journal-article" @default.
• W1626677331 hasAuthorship W1626677331A5007250146 @default.
• W1626677331 hasAuthorship W1626677331A5018005178 @default.
• W1626677331 hasAuthorship W1626677331A5051930598 @default.
• W1626677331 hasAuthorship W1626677331A5054967707 @default.
• W1626677331 hasAuthorship W1626677331A5071141746 @default.
• W1626677331 hasAuthorship W1626677331A5075011519 @default.
• W1626677331 hasAuthorship W1626677331A5082575419 @default.
• W1626677331 hasBestOaLocation W16266773311 @default.
• W1626677331 hasConcept C126322002 @default.
• W1626677331 hasConcept C146304588 @default.
• W1626677331 hasConcept C178790620 @default.
• W1626677331 hasConcept C185592680 @default.
• W1626677331 hasConcept C198451711 @default.
• W1626677331 hasConcept C2776232647 @default.
• W1626677331 hasConcept C2777575956 @default.
• W1626677331 hasConcept C2779977313 @default.
• W1626677331 hasConcept C2908647359 @default.
• W1626677331 hasConcept C44249647 @default.
• W1626677331 hasConcept C50440223 @default.
• W1626677331 hasConcept C71924100 @default.
• W1626677331 hasConcept C82789193 @default.
• W1626677331 hasConcept C99454951 @default.
• W1626677331 hasConceptScore W1626677331C126322002 @default.
• W1626677331 hasConceptScore W1626677331C146304588 @default.
• W1626677331 hasConceptScore W1626677331C178790620 @default.
• W1626677331 hasConceptScore W1626677331C185592680 @default.
• W1626677331 hasConceptScore W1626677331C198451711 @default.
• W1626677331 hasConceptScore W1626677331C2776232647 @default.
• W1626677331 hasConceptScore W1626677331C2777575956 @default.
• W1626677331 hasConceptScore W1626677331C2779977313 @default.
• W1626677331 hasConceptScore W1626677331C2908647359 @default.
• W1626677331 hasConceptScore W1626677331C44249647 @default.
• W1626677331 hasConceptScore W1626677331C50440223 @default.
• W1626677331 hasConceptScore W1626677331C71924100 @default.
• W1626677331 hasConceptScore W1626677331C82789193 @default.
• W1626677331 hasConceptScore W1626677331C99454951 @default.
• W1626677331 hasIssue "6" @default.
• W1626677331 hasLocation W16266773311 @default.

• next